文献速递心脑血管急症

脑源性神经营养因子与视锥样蛋白-1在急性卒中早期诊断中的临床价值

Clinical usefulness of brain-derived neurotrophic factor and visinin-like protein-1 in early diagnostic tests for acute stroke.
PubMed 文献 · Am J Emerg Med · 2019-02-25
一句话结论急性缺血性卒中患者入院时BDNF水平显著低于对照,可区分卒中与对照,但不能预测死亡;VILIP-1无显著鉴别能力,也不能预测死亡。

本研究纳入75例18岁以上急性缺血性卒中患者,同期从医院急诊科招募28例正常对照,入院时采血检测VILIP-1和BDNF水平。卒中组VILIP-1均值0.547±0.081 ng/mL vs 对照组0.515±0.035 ng/mL,差异无统计学意义(p=0.071)。卒中组BDNF均值3.89±2.05 ng/mL vs 对照组14.9±4.7 ng/mL,卒中组显著低于对照组(p<0.0001)。BDNF能显著区分卒中与对照患者,但未预测死亡;VILIP-1鉴别能力不显著,也未预测死亡。

要点

  • 急性缺血性卒中患者入院BDNF均值3.89±2.05 ng/mL,显著低于正常对照的14.9±4.7 ng/mL(p<0.0001)。
  • BDNF对卒中与对照有显著区分能力,但未能预测死亡。
  • 卒中组VILIP-1均值0.547±0.081 ng/mL与对照组0.515±0.035 ng/mL差异无统计学意义(p=0.071)。
  • VILIP-1对卒中与对照的鉴别能力不显著,也未预测死亡。
  • 研究纳入75例急性缺血性卒中患者和28例急诊科正常对照,仅检测入院时单次血样。

适用人群与场景

  • 年龄大于18岁的急性缺血性卒中患者75例。
  • 同期从医院急诊科招募的正常对照28例。

研究设计与关键结果

  • 研究类型为病例对照研究,纳入75例急性缺血性卒中患者和28例正常对照。
  • 卒中组VILIP-1均值0.547±0.081 ng/mL vs 对照组0.515±0.035 ng/mL,差异无统计学意义(p=0.071)。
  • 卒中组BDNF均值3.89±2.05 ng/mL vs 对照组14.9±4.7 ng/mL,卒中组显著低于对照组(p<0.0001)。
  • BDNF对卒中与对照有显著区分能力,但未预测死亡。
  • VILIP-1对卒中与对照的鉴别能力不显著,也未预测死亡。

证据类型、等级与局限

  • 证据类型:病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论提示BDNF水平可能有助于区分急性缺血性卒中患者与正常对照,但未预测死亡。
  • 原文结论提示VILIP-1水平对区分卒中患者与正常对照的能力不显著,且未预测死亡。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Lack of a rapid biochemical test for acute stroke is a limitation in the diagnosis and management of acute stroke. The aim of this study is to evaluate the efficacy of BDNF and VILIP-1 as diagnostic markers in acute ischemic stroke and as predictors of mortality.

METHODS: The study included 75 patients with acute ischemic stroke older than 18 years. During the same period, 28 normal controls were recruited from the hospital ED. Blood samples were collected from all patients at admission to determine the levels of VILIP-1 and BDNF.

RESULTS: The mean VILIP-1 levels in the study and control groups were 0.547 ± 0.081 and 0.515 ± 0.035 ng/mL, respectively, and the difference was not significant (p = 0.071). The mean BDNF levels in the study and control groups were 3.89 ± 2.05 ng/mL and 14.9 ± 4.7 ng/mL, respectively, and the level was significantly (p < 0.0001) lower in the stroke patients.

CONCLUSION: The BDNF level showed a significant ability to discriminate stroke and control patients but did not predict mortality. The VILIP-1 level showed insignificant ability to discriminate stroke patients and again did not predict mortality.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Algin A, Erdogan MO, Aydin I, et al. Clinical usefulness of brain-derived neurotrophic factor and visinin-like protein-1 in early diagnostic tests for acute stroke. Am J Emerg Med. 2019. PMID: 30826210. doi:10.1016/j.ajem.2019.02.037

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。